For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

The type 2 diabetes drug metformin helped slow aging across multiple organs, including the brain, kidneys, and the skin, a ...

New research emphasizes that replacing ultra-processed foods with healthier alternatives may help significantly reduce the ...

Ozempic and Wegovy are making so much money for Novo Nordisk A/S that their cumulative sales will soon surpass the ...

New research analyzing the effects of two drugs used to treat type 2 diabetes indicates a consistent lack of cardiovascular and renal benefits in Black populations.

A new study has revealed a startling gap in prenatal care, showing that a commonly used screening method for this condition ...

Results from the type 2 diabetes trial were published Sept. 10 in the New England Journal of Medicine, while results from the ...

Overweight or obese type 1 diabetics taking Mounjaro were able to reduce the amount of daily insulin they needed, researchers ...

Diabetes, a widespread condition affecting approximately 13% of American adults, is often accompanied by complications such ...

Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.